Study for Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma

NCT06334991 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin Lymphoma Refractory/ Relapsed

Interventions

BIOLOGICAL: CD19 t-haNK

Sponsor

ImmunityBio, Inc.